Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2009 Nov;13(11):1433-9.

Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries

A Jaquet  1 , D K Ekouevi, M Aboubakrine, J Bashi, E Messou, M Maiga, H A Traore, M Zannou, C Guehi, F O Ba-Gomis, A Minga, G Allou, S P Eholie, F Dabis, E Bissagnene, A J Sasco
Affiliations
Multicenter Study

Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries

A Jaquet et al. Int J Tuberc Lung Dis. 2009 Nov.

Abstract

Background: Tobacco smoking is common in human immunodeficiency virus (HIV) infected patients from industrialised countries. In West Africa, few data concerning tobacco consumption exist.

Methods: A cross-sectional survey of the International Epidemiological Database to Evaluate AIDS (IeDEA) network in West Africa was conducted. Health workers administered a questionnaire assessing tobacco and cannabis consumption among patients receiving antiretroviral treatment. Regular smokers were defined as current smokers who smoked >1 cigarette per day for >or=1 year.

Results: Overall, 2920 patients were enrolled in three countries. The prevalence of ever smokers and regular smokers were respectively 46.2% (95%CI 42.8-49.5) and 15.6% (95%CI 13.2-18.0) in men and 3.7% (95%CI 2.9-4.5) and 0.6% (95%CI 0.3-0.9) in women. Regular smoking was associated with being from Côte d'Ivoire or Mali compared to Benin (OR 4.6, 95%CI 2.9-7.3 and 7.7, 95%CI 4.4-13.6), severely impaired immunological status at highly active antiretroviral treatment initiation (OR 1.5, 95%CI 1.1-2.2) and history of tuberculosis (TB; OR 1.8, 95%CI 1.1-3.0).

Conclusion: There are marked differences in smoking prevalence among these West African countries. This survey approach also provides proof of the association between cigarette smoking and TB in HIV-infected patients, a major public health issue in this part of the world.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated smoking prevalence (with 95% upper limit of confidence interval) according to gender and country (n=2920). The IeDEA West Africa collaboration, 2007–2008 *Regular smokers are defined as present smokers declaring one or more cigarette per day for at least one year.
See this image and copyright information in PMC

References

    1. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005 Feb;34(1):121–30. - PubMed
    1. Benard A, Tessier JF, Rambeloarisoa J, Bonnet F, Fossoux H, Neau D, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis. 2006 Apr;10(4):378–83. - PubMed
    1. Collins RL, Kanouse DE, Gifford AL, Senterfitt JW, Schuster MA, McCaffrey DF, et al. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol. 2001 Sep;20(5):351–60. - PubMed
    1. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d’Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS. 2003 May 23;17(8):1179–93. - PubMed
    1. Gritz ER, Vidrine DJ, Lazev AB, Amick BC, 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004 Feb;6(1):71–7. - PubMed

Publication types

MeSH terms

Substances